KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Change in Inventory (2016 - 2025)

Neogenomics (NEO) has disclosed Change in Inventory for 16 consecutive years, with $28000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 98.78% year-over-year to $28000.0, compared with a TTM value of $1.5 million through Dec 2025, down 42.83%, and an annual FY2025 reading of $1.5 million, down 42.83% over the prior year.
  • Change in Inventory was $28000.0 for Q4 2025 at Neogenomics, up from -$5.6 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $4.1 million in Q2 2025 and bottomed at -$5.6 million in Q3 2025.
  • Average Change in Inventory over 5 years is $208100.0, with a median of $447000.0 recorded in 2021.
  • Peak annual rise in Change in Inventory hit 1034.16% in 2024, while the deepest fall reached 2018.0% in 2024.
  • Year by year, Change in Inventory stood at $1.6 million in 2021, then crashed by 55.38% to $697000.0 in 2022, then plummeted by 71.02% to $202000.0 in 2023, then surged by 1034.16% to $2.3 million in 2024, then crashed by 98.78% to $28000.0 in 2025.
  • Business Quant data shows Change in Inventory for NEO at $28000.0 in Q4 2025, -$5.6 million in Q3 2025, and $4.1 million in Q2 2025.